Target intelligence / Profile preview

MicroRNA 548d-1 (MIR548D1)

Target
MIR548D1
Molecular classification
microRNA, non-coding RNA
01

Overview

MicroRNA 548d-1 (MIR548D1) is a small (20–24 nucleotides), non-coding RNA belonging to the microRNA family, encoded in the human genome and transcribed by RNA polymerase II[2]. It is processed from a primary transcript via Drosha and Dicer into a mature miRNA, which associates with the RNA-induced silencing complex (RISC) to regulate diverse target mRNAs, typically resulting in translational repression or mRNA destabilization[2]. MIR548D1 is implicated in the regulation of cell proliferation, survival, apoptosis, and participates in several critical signaling pathways. It has experimentally observed or predicted roles in tumorigenesis, including in breast, colorectal, lung cancers, and has been identified as a possible player in neuronal and somatic diseases[1][2]. Computational studies suggest its sequence may also inhibit flavivirus (e.g., hepatitis C virus, dengue, zika) capsid gene expression, with early-stage bioinformatic evidence pointing towards antiviral therapeutic potential, though this is preclinical[1]. As a microRNA, it is not a classic "drug target" receptor or enzyme, but may be investigated therapeutically via RNA-based strategies or as a biomarker[2].

Other names
hsa-mir-548d-1MIRN548D1hsa-miR-548d-3p
02

Biological functions

post-transcriptional regulation of gene expressiontranslational repressionmRNA destabilizationcell proliferationapoptosisinvolvement in signaling pathways (e.g., MAPK, PI3K, p53, B-cell receptor, T-cell receptor, TGF-beta, PPAR, calcium, insulin)
03

Disease associations

Cancer (breast cancer, colorectal cancer, glioma, non-small cell lung cancer)Autonomic nervous system diseaseSomatoform disorderpotential antiviral role (Flaviviridae infections, such as hepatitis C, dengue, zika)
04

Biomarkers

cancer-type classifier (in machine learning tissue-of-origin studies)possible marker in ovarian follicle functionpotentially as a viral infection biomarker (preclinical, not clinical)

Beyond the preview

Go deeper on MicroRNA 548d-1 (MIR548D1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 548d-1 (MIR548D1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call